Leukemia inhibitory factor signaling drives immunosuppression and neuroendocrine differentiation in prostate cancer

被引：0
|
作者：
Liu, Y. [1 ]
Liu, M. [1 ]
Wen, Y. [4 ]
Yeh, H. [1 ]
Chen, W. [1 ,2 ]
Jiang, K. [1 ]
Li, H. [1 ]
Chen, Z. [3 ]
Wang, W. [3 ]
Chen, W. [1 ,2 ]
机构：
[1] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Coll Med Sci & Technol, Taipei, Taiwan
[2] Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei, Taiwan
[3] Taipei Med Univ, Sch Pharm, Div Clin Pharm, Taipei, Taiwan
[4] Taipei Med Univ, Wan Fang Hosp, Dept Urol, Taipei, Taiwan
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.07.593
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO44-2
引用
收藏
页码：S1351 / S1351
页数：1
相关论文
共 50 条
  • [41] Immunohistochemical Analysis of Neuroendocrine Differentiation in Prostate Cancer
    Ishida, Eiwa
    Nakamura, Mitsutoshi
    Shimada, Keiji
    Tasaki, Masato
    Konishi, Noboru
    PATHOBIOLOGY, 2009, 76 (01) : 30 - 38
  • [42] Molecular aspects of prostate cancer with neuroendocrine differentiation
    Li, Qi
    Zhang, Connie S.
    Zhang, Yifen
    CHINESE JOURNAL OF CANCER RESEARCH, 2016, 28 (01) : 122 - 129
  • [43] Clinical implications of neuroendocrine differentiation in prostate cancer
    Nelson, E. C.
    Cambio, A. J.
    Yang, J. C.
    Ok, J-H
    Lara, P. N., Jr.
    Evans, C. P.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2007, 10 (01) : 6 - 14
  • [44] Clinical implications of neuroendocrine differentiation in prostate cancer
    E C Nelson
    A J Cambio
    J C Yang
    J-H Ok
    P N Lara
    C P Evans
    Prostate Cancer and Prostatic Diseases, 2007, 10 : 6 - 14
  • [45] Neuroendocrine differentiation in prostate cancer: Is it detectable and treatable?
    Birtle, AJ
    Freeman, A
    Payne, HA
    Masters, JRW
    Harland, SJ
    BJU INTERNATIONAL, 2003, 92 (04) : 490 - 490
  • [46] Elucidating Leukemia Inhibitory Factor (LIF) on Prostate Cancer Bone Metastasis Microenvironment
    Galera, Cayetano
    Cuartas, Isabel
    Seoane, Joan
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 237 - 237
  • [47] Human ASH1 transcription factor expression in prostate cancer with neuroendocrine differentiation
    Volante, Marco
    Rapa, Ida
    Ceppi, Paolo
    Bollito, Enrico
    Rosas, Rosj
    Bacillo, Elisa
    Cappia, Susanna
    Scagliotti, Giorgio
    Berruti, Alfredo
    Papotti, Mauro
    VIRCHOWS ARCHIV, 2007, 451 (02) : 139 - 139
  • [48] Growth Factor Midkine is Associated With Castration-resistant Prostate Cancer and Neuroendocrine Differentiation
    Nordin, A.
    Wang, W.
    Welen, K.
    Damber, J. E.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S176 - S176
  • [49] MAPK/ERK signaling mediates melatonin-induced neuroendocrine differentiation in prostate cancer cells
    Sainz, R. M.
    Hevia, D.
    Quiros, I.
    Mayo, J. C.
    EJC SUPPLEMENTS, 2008, 6 (09): : 86 - 86
  • [50] Notch Signaling Modulates Hypoxia-Induced Neuroendocrine Differentiation of Human Prostate Cancer Cells
    Danza, Giovanna
    Di Serio, Claudia
    Rosati, Fabiana
    Lonetto, Giuseppe
    Sturli, Niccolo
    Kacer, Doreen
    Pennella, Antonio
    Ventimiglia, Giuseppina
    Barucci, Riccardo
    Piscazzi, Annamaria
    Prudovsky, Igor
    Landriscina, Matteo
    Marchionni, Niccolo
    Tarantini, Francesca
    MOLECULAR CANCER RESEARCH, 2012, 10 (02) : 230 - 238
12345